Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Internal Jugular Vein Ultrasound and Acute Kidney Injury After Abdominal Surgery (PRO-JUGULAR)

7. september 2026 oppdatert av: Matild Keresztes, Tîrgu Mureș Emergency Clinical County Hospital, Romania

Dynamic Internal Jugular Vein Assessment During Anesthesia Induction as a Predictor of Hemodynamic Instability and Postoperative Outcomes

This observational study aims to learn whether changes in the internal jugular vein during anesthesia induction can help predict low blood pressure and kidney injury after surgery. The main questions it aims to answer are:

  1. Can the internal jugular vein collapsibility index before anesthesia predict low blood pressure during induction?
  2. Can the change in internal jugular vein collapsibility from before to just after anesthesia predict low blood pressure during surgery and acute kidney injury after surgery?

Participants will have routine ultrasound scans of the neck before anesthesia and again shortly after they fall asleep for surgery. Researchers will also record blood pressure during surgery and measure kidney function after surgery using routine blood tests. and again shortly after they fall asleep for surgery. Researchers will also record blood pressure during surgery and measure kidney function after surgery using routine blood tests.

Studieoversikt

Detaljert beskrivelse

This is a single-centre prospective observational study of adults undergoing major abdominal or visceral surgery under general anesthesia. The study is designed to see whether bedside ultrasound measurements of the internal jugular vein can help identify participants who are at risk of low blood pressure during anesthesia induction and acute kidney injury after surgery.

Participants will have one ultrasound scan while awake before anesthesia and a second scan shortly after loss of consciousness following propofol induction. The researchers will calculate the internal jugular vein collapsibility index from both scans and determine the change between them. They will then compare these measurements with blood pressure changes during the induction period and with postoperative kidney function, which will be assessed using routine creatinine tests.

The study includes adults aged 18 years and older who are having elective or urgent non-emergency major abdominal or visceral surgery. Participants must receive propofol for anesthesia induction and must have blood pressure monitoring during surgery. People with emergency surgery, dependence on dialysis, major anatomic abnormalities that prevent ultrasound scanning of the neck, or other conditions that would invalidate the ultrasound measurement will not be included.

The study does not change routine anesthesia care. The ultrasound scans and blood tests are added only for research purposes, and the results are intended to help predict risk rather than guide treatment during the study itself.

Studietype

Observasjonsmessig

Registrering (Antatt)

150

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Mureș County
      • Târgu Mureş, Mureș County, Romania, 540136
        • Rekruttering
        • County Emergency Clinical Hospital of Targu Mureș
        • Ta kontakt med:
          • Janos Szederjesi, MD, PhD Assoc Prof
          • Telefonnummer: +40745316221
          • E-post: yangzi37@gmail.com
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Prøvetakingsmetode

Sannsynlighetsprøve

Studiepopulasjon

The study population consists of adults aged 18 years and older undergoing major abdominal or visceral surgery under general anesthesia with propofol induction at the Department of Anestesiology and Intensive Care Department in the Emergency County Hospital in Târgu Mureș. Patients will be enrolled prospectively in the preoperative period if they meet eligibility criteria, have routine perioperative blood pressure monitoring, and are able to undergo internal jugular vein ultrasound before and immediately after induction. The cohort will be followed through postoperative days 1 to 3 for creatinine-based assessment of acute kidney injury.

Beskrivelse

Inclusion Criteria:

  • Elective or Urgent (Non-emergent) major abdominal/ visceral surgery under general anesthesia
  • General anesthesia with propofol induction (TCI/ manual)
  • Expected surgical duration > 60 minutes
  • Continous BP monitoring (Invasive arterial line or non-invasive cuff at 2 minute recording intervals)
  • Serum creatinine and eGFR (CKD-EPI) available within 30 days prior to surgery
  • Written informed consent obtained before surgery
  • Patient accessible by phone 30 days postoperatively

Exclusion Criteria:

  • Emergency surgery (immediate life-saving, consent unobtainable)
  • End-stage renal disease (eGFR < 15 mL/min/1.73 m²) or dialysis-dependent
  • Concomitant cardiac surgery or carotid endarterectomy
  • Liver transplantation
  • Known Internal Jugular Vein/ Inferior Vena Cava thrombosis or Superior Vena Cava syndrome
  • Any anatomical neck abnormalities precluding Internal jugular vein ultrasound
  • Induction with ketamine or etomidate as sole Induction agent
  • Neuraxial anesthesia (spinal or epidural) before propofol induction
  • Active decompensated heart failure (NYHA IV or acute pulmonary edema at time of Surgery)
  • Same-admission reoperation within 30-day study window
  • Withdrawal of consent at any point

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
Intervensjon / Behandling
Propofol Peri-induction IJV cohort
Prospective observational cohort of adult patients undergoing elective or urgent non-emergent major abdominal or visceral surgery under general anesthesia with propofol induction. Participants will undergo pre-induction and immediate post-induction internal jugular vein ultrasound measurements to evaluate whether changes in internal jugular vein collapsibility predict post-induction hypotension and postoperative acute kidney injury.
Point-of-care Internal jugular vein ultrasound performed before induction and immediately after propofol induction to measure vein diameter and collapsibility index.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Post-induction hypotension
Tidsramme: Periprocedural
Incidence of mean arterial pressure below 65 mmHg for atleast one consecutive minute during propofol induction
Periprocedural
Change in Internal Jugular Vein Collapsibility Index
Tidsramme: From pre-induction to immediate post-induction
Difference between pre-induction and immediate post-induction internal jugular vein collapsibility index measured by point-of-care ultrasound
From pre-induction to immediate post-induction

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Postoperative Acute Kidney Injury
Tidsramme: Postoperative days one to three
Acute Kidney Injury defined according to KDIGO criteria based on postoperative serum creatinine measurements
Postoperative days one to three
Cumulative Intra-operative Hypotension Burden
Tidsramme: Induction to End of Surgery
Total duration of mean arterial pressure threshold of 65 mmHg during the operative period
Induction to End of Surgery

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Cummulative Intra-operative Hypotension burden
Tidsramme: Induction to End of surgery
Area under the mean arterial pressure threshold of 65 mmHg during the operative period
Induction to End of surgery

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

7. september 2026

Primær fullføring (Antatt)

31. januar 2027

Studiet fullført (Antatt)

28. mars 2027

Datoer for studieregistrering

Først innsendt

21. mai 2026

Først innsendt som oppfylte QC-kriteriene

4. juni 2026

Først lagt ut (Faktiske)

10. juni 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

10. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

7. september 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

UBESLUTTE

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere